FDA Greenlights Updated COVID-19 Vaccines; Bivalent Vaccines No Longer Authorized
The bivalent Pfizer-BioNTech and Moderna COVID-19 vaccines are no longer authorized for use in the United States.
The bivalent Pfizer-BioNTech and Moderna COVID-19 vaccines are no longer authorized for use in the United States.
Veklury is a SARS-CoV-2 nucleotide analog RNA polymerase inhibitor.
Moderna says it will be ready to provide the updated vaccine for the upcoming fall vaccination season once authorized by the FDA.
Abyrsvo is the first vaccine approved for pregnant individuals to prevent RSV disease in infants.
Significant reduction seen in incidence of major adverse cardiovascular event over median follow-up of 5.1 years.
.
COVID-19 induces a range of negative cardiac effects, such as hypoxic respiratory failure and hypoxemia, microvascular injury, venous thromboembolism, and pulmonary embolism.
A phase 1/2 trial is evaluating the gene therapy in adult patients with HIV-1 who are on stable ART.
Beyfortus is expected to be available for the upcoming 2023-2024 RSV season.
The is the first approval of an oral antiviral therapy for COVID-19.
Consumers in possession of tests with the affected lot numbers should dispose of them.